Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by LAMBERT, C. M.
Right arrow Articles by FORBES, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAMBERT, C. M.
Right arrow Articles by FORBES, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 British Society for Rheumatology


research-article

A PILOT STUDY OF THE ECONOMIC COST AND CLINICAl OUTCOME OF DAY PATIENT VS INPATIENT MANAGEMENT OF ACTIVE RHEUMATOID ARTHRITIS

C. M. LAMBERT*, N. P. HURST*,, A. LOCHHEAD*, K. MCGREGOR*, M. HUNTER* and J. FORBES{dagger}

*Economic and Health Outcomes Research Group, Rheumatic Diseases Unit, Western General Hospital Edinburgh
{dagger}Department of Public Health Sciences, Medical School, University of Edinburgh

Correspondence to: Correspondence to: N. P. Hurst, EcHO Research Group, Rheumatic Diseases Unit, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU.

The aims of this pilot study, which compares day patient with inpatient care for management of active RA were (i) to test feasibility of a trial protocol design including the method of randomization and the practicality of data collection, and to obtain preliminary information on economic cost and clinical outcome of these two methods of management.Twenty consecutive patients requiring admission for management of active RA were randomized to receive either day patient or inpatient care. All hospital, transport, community and indirect costs incurred over a 6-month period from recruitment were collected for each patient. Disease activity and clinical outcome were assessed using the Ritchie articular index, ESR, Health Assessment Questionnaire, Functional Independence Measure and Hospital Anxiety and Depression Scale. The trial protocol was found to be feasible and no patient allocated to the day patient group requested or required to transferred to inpatient care. Day care was significantly cheaper than inpatient care despite higher transport costs; the total cost of treating 10 day patients was UK£ 10 272 compared with£14 528 for 10 inpatients. Clinical outcome was comparable in both groups for all parameters studied and there was no obvious detrimental effect on patients receiving care. This pilot study demonstrates that day care is feasible and acceptable to patients with active RA. The preliminary data suggest that day care is substantially cheaper than inpatient care and does not apparently compromise clinical outcome.

KEY WORDS: Rheumatoid arthritis, Day care, Outcome, Therapy, Health economics


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
T. P. M. Vliet Vlieland
Non-drug care for RA is the era of evidence-based practice approaching?
Rheumatology, September 1, 2007; 46(9): 1397 - 1404.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C M. Lambert, N. P Hurst, J. F Forbes, A. Lochhead, M. Macleod, and G. Nuki
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation
BMJ, March 28, 1998; 316(7136): 965 - 969.
[Abstract] [Full Text]


Home page
BMJHome page
A. Bradlow and J. David
Recent Advances: Rheumatology
BMJ, March 11, 1995; 310(6980): 637 - 640.
[Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.